Europe - FRA:LO3 - CH0013841017 - Common Stock
The current stock price of LO3.DE is 580.6 EUR. In the past month the price decreased by -6.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.65 | 174.63B | ||
1DHR.MI | DANAHER CORP | 28.53 | 131.68B | ||
DAP.DE | DANAHER CORP | 27.88 | 128.77B | ||
QTS.DE | IQVIA HOLDINGS INC | 18.15 | 30.33B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 47.7 | 19.17B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 47.7 | 19.17B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 50.97 | 16.60B | ||
SRT.DE | SARTORIUS AG | 41.7 | 13.58B | ||
ILU.DE | ILLUMINA INC | 23.36 | 12.82B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 17.31 | 11.35B | ||
ERF.PA | EUROFINS SCIENTIFIC | 17.29 | 11.34B | ||
QIA.DE | QIAGEN N.V. | 19.98 | 8.71B |
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,299 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
LONZA GROUP AG-REG
Muenchensteinerstrasse 38
Basel BASEL-STADT CH
Employees: 19299
Phone: 41613168111
The current stock price of LO3.DE is 580.6 EUR. The price decreased by -2.91% in the last trading session.
The exchange symbol of LONZA GROUP AG-REG is LO3 and it is listed on the Deutsche Boerse Ag exchange.
LO3.DE stock is listed on the Deutsche Boerse Ag exchange.
30 analysts have analysed LO3.DE and the average price target is 732.76 EUR. This implies a price increase of 26.21% is expected in the next year compared to the current price of 580.6. Check the LONZA GROUP AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LONZA GROUP AG-REG (LO3.DE) has a market capitalization of 40.78B EUR. This makes LO3.DE a Large Cap stock.
LONZA GROUP AG-REG (LO3.DE) currently has 19299 employees.
LONZA GROUP AG-REG (LO3.DE) has a resistance level at 588.71. Check the full technical report for a detailed analysis of LO3.DE support and resistance levels.
The Revenue of LONZA GROUP AG-REG (LO3.DE) is expected to grow by 14.55% in the next year. Check the estimates tab for more information on the LO3.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LONZA GROUP AG-REG (LO3.DE) has a dividend yield of 0.74%. The yearly dividend amount is currently 4.27. Check the full fundamental report for a detailed analysis of LO3.DE dividend history, reliability and sustainability.
LONZA GROUP AG-REG (LO3.DE) will report earnings on 2026-01-27, after the market close.
The PE ratio for LONZA GROUP AG-REG (LO3.DE) is 34.89. This is based on the reported non-GAAP earnings per share of 16.64 and the current share price of 580.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for LO3.DE.
ChartMill assigns a technical rating of 2 / 10 to LO3.DE.
ChartMill assigns a fundamental rating of 5 / 10 to LO3.DE. LO3.DE has an average financial health and profitability rating.
Over the last trailing twelve months LO3.DE reported a non-GAAP Earnings per Share(EPS) of 16.64. The EPS increased by 16.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.33% | ||
ROA | 4.1% | ||
ROE | 7.84% | ||
Debt/Equity | 0.39 |
30 analysts have analysed LO3.DE and the average price target is 732.76 EUR. This implies a price increase of 26.21% is expected in the next year compared to the current price of 580.6.
For the next year, analysts expect an EPS growth of 11.86% and a revenue growth 14.55% for LO3.DE